UW BESTELLING
Uw winkelwagen is leeg
Begin met het toevoegen van onderzoekspeptiden aan uw winkelwagen.
MISSCHIEN OOK INTERESSANT
Uw winkelwagen is leeg
Begin met het toevoegen van onderzoekspeptiden aan uw winkelwagen.
MISSCHIEN OOK INTERESSANT
A long-acting GLP-1 receptor agonist peptide used in metabolic research, with a modified structure that extends its half-life to approximately one week.
Semaglutide is a synthetic analogue of human glucagon-like peptide-1 (GLP-1) with 94% amino acid sequence homology to native GLP-1, engineered with key modifications that extend its half-life to approximately 7 days, enabling once-weekly dosing. These modifications include an amino acid substitution at position 8 (Aib for Ala) to resist DPP-4 degradation, and acylation with a C18 fatty diacid chain at position 26 to promote albumin binding and slow renal clearance. Semaglutide activates the GLP-1 receptor to enhance glucose-dependent insulin secretion, suppress glucagon, delay gastric emptying, and reduce appetite through central nervous system satiety pathways. While effective as a single-mechanism GLP-1 agonist, research has shown that dual-agonist approaches like tirzepatide (GIP/GLP-1) may produce superior outcomes in body weight reduction. Semaglutide remains one of the most significant peptide therapeutics developed in metabolic research.
Glucagon-Like Peptide-1, an incretin hormone that regulates blood sugar, slows gastric emptying, and reduces appetite, targeted by semaglutide and tirzepatide.
A first-in-class dual GIP/GLP-1 receptor agonist peptide with superior metabolic efficacy, acting on both incretin pathways simultaneously.
Glucose-dependent Insulinotropic Polypeptide receptor, a key target in metabolic peptide research that mediates insulin secretion and energy homeostasis.
The time required for the concentration of a substance in the body to decrease by 50%, a key pharmacokinetic parameter determining dosing frequency.
The fundamental building blocks of peptides and proteins, with 20 standard types that combine in unique sequences to create biologically active molecules.
Body Protection Compound-157, a synthetic 15-amino acid peptide derived from human gastric juice with potent tissue-healing and neuroprotective properties.
Legal under MHRA rules. BPC-157, tirzepatide & NAD+ pens with next-day UK delivery from £99. >99% purity, GMP certified. Shop now.
ARTICLEPens cut dosing error from 15% to under 2%. We compare accuracy, contamination risk, cost, and convenience. See why researchers are switching in 2026.
ARTICLEOver 100 published studies back BPC-157 for tissue repair, gut healing, and neuroprotection. Mechanisms, dosing protocols, and where to buy in the UK.
COMPARISONVergelijk BPC-157 en TB-500 voor herstelonderzoek. Mechanismen, voordelen, dosering en wanneer elk peptide te gebruiken. Koop beide als voorgemengde pennen.
COMPARISONVergelijk tirzepatide en semaglutide voor metabolisch onderzoek. Dubbel vs enkel receptor, werkzaamheidsgegevens, bijwerkingen en prijzen. Koop tirzepatide pennen.
ENCYCLOPEDIAGastric Pentadecapeptide. Molecuulgewicht: 1419.53 Da. Verken het werkingsmechanisme, belangrijke studies en onderzoekstoepassingen.
BUNDLEHet klassieke genezingsduo voor versneld weefselherstel
PROTOCOLOnderzoeksprotocol dat BPC-157 en TB-500 peptide-pens combineert voor versneld weefselherstel. Verken synergistische geneesmechanismen, doseerschema's en gepubliceerde studieresultaten.
FAQAlles over peptide pensystemen. Hoe voorgemengde peptide pennen werken, voordelen boven injectieflacons en doseermechanismen.
CATEGORYResearch-grade recovery peptide pens. BPC-157 and TB-500 for tissue repair, wound healing, and inflammation research. >99% purity, UK delivery.
CATEGORYResearch-grade weight loss peptide pens. Tirzepatide dual GIP/GLP-1 agonist for metabolic research. Pre-mixed pens, >99% purity, next-day UK delivery.
Premium pre-mixed peptide pens with next-day UK delivery. GMP manufactured, >99% purity guaranteed.
SHOP ALL PEPTIDES
